EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antihypertensive Medications and Risk of Heat‐Related Illness During Heatwaves: Self‐Controlled Case Series

Mia Harley iD, Masao Iwagami, Chitose Kawamura, Elizabeth Williamson, Christopher T Rentsch iD, Rohini Mathur, Ian J Douglas, Dorothea Nitsch, Yuta Taniguchi, Yoko Hamasaki, Ai Suzuki, Naoaki Kuroda und 3 weitere

Pharmacoepidemiology and Drug Safety · 2026-09 · 35 (9)

DOI: 10.1002/pds.70447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 08.09.2026. Verfasst von Mia Harley und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, L…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Hot Temperature, Heat Stress Disorders. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Barts Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate whether antihypertensive medications modify the risk of heat‐related illness during heatwaves among adults with hypertension in Japan.

Methods

We identified adults with hypertension in Tsukuba City administrative claims data between April 2014 and March 2019. Average daily temperature was derived from Japan Meteorological Agency data. We used a self‐controlled case series (SCCS) design to estimate incidence rate ratios (IRRs) for heat‐related illness during 5‐day pre‐heatwave, heatwave and 5‐day post‐heatwave periods compared to baseline within individuals. The main analysis was stratified by person‐time prescribed antihypertensives (angiotensin‐converting enzyme [ACE] inhibitors/angiotensin II receptor blockers [ARBs], calcium channel blockers [CCBs] or non‐loop diuretics) and person‐time not prescribed antihypertensives, with drug‐temperature interaction assessed. Subgroup analyses were conducted for each antihypertensive class. All models were adjusted for age and season.

Results

We observed a greater increase in the rate of heat‐related illness during heatwaves versus baseline among person‐time prescribed antihypertensives (IRR: 1.64, 95% CI: 1.53–1.75) than among person‐time not prescribed antihypertensives (IRR: 1.42, 95% CI: 1.27–1.58), with evidence of drug‐temperature interaction ( p < 0.01). When examining individual drug classes, ACE inhibitors/ARBs and CCBs were associated with an increased risk of heat‐related illness during heatwaves, whereas there was no evidence of an effect with diuretics.

Conclusions

Our findings indicate that people taking antihypertensives are more vulnerable to heat‐related illnesses during heatwaves. More research is required to explore whether this is a causal effect of the medication or due to differences between those who are treated and untreated with antihypertensives that are related to the outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHot TemperatureHeat Stress DisordersExtreme HeatHumansFemaleJapanAgedMaleMiddle AgedIncidenceCalcium Channel BlockersAdultRisk FactorsAged, 80 and over

Stichwörter der Autor:innen

antihypertensivesheatwavesheat‐related illnesshypertensionself‐controlled case series

Substanzen

Antihypertensive AgentsCalcium Channel Blockers

Autor:innen und Institutionen

  • Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
  • Department of Digital Health, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan.
  • Digital Society Division, Center for Cyber Medicine Research, University of Tsukuba, Ibaraki, Japan.
  • Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Mia Harley, Christopher T Rentsch, Angel Y S Wong

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Barts Charity

Zitieren

APA

Harley, M., Iwagami, M., Kawamura, C., Williamson, E., Rentsch, C. T., Mathur, R., Douglas, I. J., Nitsch, D., Taniguchi, Y., Hamasaki, Y., Suzuki, A., Kuroda, N., Komiyama, J., Wong, A. Y. S., & Tamiya, N. (2026). Antihypertensive Medications and Risk of Heat‐Related Illness During Heatwaves: Self‐Controlled Case Series. Pharmacoepidemiology and Drug Safety, 35(9). https://doi.org/10.1002/pds.70447

Vancouver

Harley M, Iwagami M, Kawamura C, Williamson E, Rentsch CT, Mathur R, et al. Antihypertensive Medications and Risk of Heat‐Related Illness During Heatwaves: Self‐Controlled Case Series. Pharmacoepidemiology and Drug Safety. 2026;35(9). doi:10.1002/pds.70447

BibTeX
@article{Harley2026,
  author = {Harley, Mia and Iwagami, Masao and Kawamura, Chitose and Williamson, Elizabeth and Rentsch, Christopher T and Mathur, Rohini and Douglas, Ian J and Nitsch, Dorothea and Taniguchi, Yuta and Hamasaki, Yoko and Suzuki, Ai and Kuroda, Naoaki and Komiyama, Jun and Wong, Angel Y S and Tamiya, Nanako},
  title = {Antihypertensive Medications and Risk of Heat‐Related Illness During Heatwaves: Self‐Controlled Case Series},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {9},
  doi = {10.1002/pds.70447}
}
Kostenlos starten →